Last 12 months
Inside the activity.
0 purchase rows · 78 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 2 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 1 |
| Feb 2026 | 0 | 35 |
| Mar 2026 | 0 | 13 |
| Apr 2026 | 0 | 9 |
| May 2026 | 0 | 12 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 1 |
| Aug 2026 | 0 | 2 |
| Sep 2026 | 0 | 3 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 13, 2020 Filed Feb 14, 2020 21:10 UTC |
Landry Robert EEVP Finance CFO
|
SaleCommon Stock | 4 | $402.30 | $1,609.20 |
DisclosureSEC source: 0001237899-20-000009 · edgardoc.xml · nonDerivative · entry 7 Landry Robert E · CIK 0001585160 · EVP Finance CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,978 F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c). Read SEC document |
| February 13, 2020 Filed Feb 14, 2020 21:10 UTC |
Landry Robert EEVP Finance CFO
|
SaleCommon Stock | 8 | $401.70 | $3,213.60 |
DisclosureSEC source: 0001237899-20-000009 · edgardoc.xml · nonDerivative · entry 6 Landry Robert E · CIK 0001585160 · EVP Finance CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,982 F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c). Read SEC document |
| February 13, 2020 Filed Feb 14, 2020 21:10 UTC |
Landry Robert EEVP Finance CFO
|
SaleCommon Stock | 21 | $400.54 | $8,411.34 |
DisclosureSEC source: 0001237899-20-000009 · edgardoc.xml · nonDerivative · entry 5 Landry Robert E · CIK 0001585160 · EVP Finance CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,990 F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c). F4 · price: Represents volume-weighted average price of sales of 21 shares of Company stock on February 13, 2020 at prices ranging from $400.20 to $400.93. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 13, 2020 at each separate price. Read SEC document |
| February 13, 2020 Filed Feb 14, 2020 21:10 UTC |
Landry Robert EEVP Finance CFO
|
SaleCommon Stock | 22 | $399.89 | $8,797.58 |
DisclosureSEC source: 0001237899-20-000009 · edgardoc.xml · nonDerivative · entry 4 Landry Robert E · CIK 0001585160 · EVP Finance CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,011 F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c). F3 · price: Represents volume-weighted average price of sales of 22 shares of Company stock on February 13, 2020 at prices ranging from $399.78 to $399.97. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 13, 2020 at each separate price. Read SEC document |
| February 13, 2020 Filed Feb 14, 2020 21:10 UTC |
Landry Robert EEVP Finance CFO
|
SaleCommon Stock | 47 | $398.63 | $18,735.61 |
DisclosureSEC source: 0001237899-20-000009 · edgardoc.xml · nonDerivative · entry 3 Landry Robert E · CIK 0001585160 · EVP Finance CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,033 F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c). F2 · price: Represents volume-weighted average price of sales of 47 shares of Company stock on February 13, 2020 at prices ranging from $398.62 to $398.87. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 13, 2020 at each separate price. Read SEC document |
| February 13, 2020 Filed Feb 14, 2020 21:09 UTC |
STAHL NEILEVP Research and Development
|
SaleCommon Stock | 31 | $406.44 | $12,599.64 |
DisclosureSEC source: 0001237899-20-000008 · edgardoc.xml · nonDerivative · entry 7 STAHL NEIL · CIK 0001226689 · EVP Research and Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,380 F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c). Read SEC document |
| February 13, 2020 Filed Feb 14, 2020 21:09 UTC |
STAHL NEILEVP Research and Development
|
SaleCommon Stock | 1,279 | $402.35 | $514,605.65 |
DisclosureSEC source: 0001237899-20-000008 · edgardoc.xml · nonDerivative · entry 6 STAHL NEIL · CIK 0001226689 · EVP Research and Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,411 F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c). F5 · price: Represents volume-weighted average price of sales of 1,279 shares of Company stock on February 13, 2020 at prices ranging from $402.04 to $402.97. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 13, 2020 at each separate price. Read SEC document |
| February 13, 2020 Filed Feb 14, 2020 21:09 UTC |
STAHL NEILEVP Research and Development
|
SaleCommon Stock | 2,058 | $401.46 | $826,204.68 |
DisclosureSEC source: 0001237899-20-000008 · edgardoc.xml · nonDerivative · entry 5 STAHL NEIL · CIK 0001226689 · EVP Research and Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,690 F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c). F4 · price: Represents volume-weighted average price of sales of 2,058 shares of Company stock on February 13, 2020 at prices ranging from $401.11 to $401.97. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 13, 2020 at each separate price. Read SEC document |
| February 13, 2020 Filed Feb 14, 2020 21:09 UTC |
STAHL NEILEVP Research and Development
|
SaleCommon Stock | 2,608 | $400.54 | $1,044,608.32 |
DisclosureSEC source: 0001237899-20-000008 · edgardoc.xml · nonDerivative · entry 4 STAHL NEIL · CIK 0001226689 · EVP Research and Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,748 F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c). F3 · price: Represents volume-weighted average price of sales of 2,608 shares of Company stock on February 13, 2020 at prices ranging from $400.01 to $400.93. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 13, 2020 at each separate price. Read SEC document |
| February 13, 2020 Filed Feb 14, 2020 21:09 UTC |
STAHL NEILEVP Research and Development
|
SaleCommon Stock | 4,302 | $399.80 | $1,719,939.60 |
DisclosureSEC source: 0001237899-20-000008 · edgardoc.xml · nonDerivative · entry 3 STAHL NEIL · CIK 0001226689 · EVP Research and Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,356 F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c). F2 · price: Represents volume-weighted average price of sales of 4,302 shares of Company stock on February 13, 2020 at prices ranging from $399.04 to $399.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 13, 2020 at each separate price. Read SEC document |
| February 12, 2020 Filed Feb 14, 2020 21:10 UTC |
Landry Robert EEVP Finance CFO
|
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 500 | $0.00 Strike: $272.70 | $0.00 |
DisclosureSEC source: 0001237899-20-000009 · edgardoc.xml · derivative · entry 10 Landry Robert E · CIK 0001585160 · EVP Finance CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,500 Underlying: Common Stock · 500 shares Expires 2023-09-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c). F5 · derivative.exercise_date: The stock option award vests in four equal annual installments, commencing one year after the date of grant. Read SEC document |
| February 12, 2020 Filed Feb 14, 2020 21:10 UTC |
Landry Robert EEVP Finance CFO
|
Tax withholdingCommon Stock | 393 | $402.34 | $158,119.62 |
DisclosureSEC source: 0001237899-20-000009 · edgardoc.xml · nonDerivative · entry 2 Landry Robert E · CIK 0001585160 · EVP Finance CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,080 F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c). Read SEC document |
| February 12, 2020 Filed Feb 14, 2020 21:10 UTC |
Landry Robert EEVP Finance CFO
|
Exercise / conversionCommon Stock | 500 | $272.70 | $136,350.00 |
DisclosureSEC source: 0001237899-20-000009 · edgardoc.xml · nonDerivative · entry 1 Landry Robert E · CIK 0001585160 · EVP Finance CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,473 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c). Read SEC document |
| February 12, 2020 Filed Feb 14, 2020 21:09 UTC |
STAHL NEILEVP Research and Development
|
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 25,000 | $0.00 Strike: $52.03 | $0.00 |
DisclosureSEC source: 0001237899-20-000008 · edgardoc.xml · derivative · entry 11 STAHL NEIL · CIK 0001226689 · EVP Research and Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63,079 Underlying: Common Stock · 25,000 shares Expires 2021-12-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c). F6 · derivative.exercise_date: With respect to 75,000 underlying shares (of which 50,000 remain outstanding), the option became exercisable on December 31, 2014, based upon the satisfaction by the company of certain performance criteria during the period ended December 31, 2014. With respect to 48,079 underlying shares (of which 13,079 remain outstanding), the stock option award vested in four equal annual installments, commencing one year after the date of grant. Read SEC document |
| February 12, 2020 Filed Feb 14, 2020 21:09 UTC |
STAHL NEILEVP Research and Development
|
Tax withholdingCommon Stock | 14,722 | $402.34 | $5,923,249.48 |
DisclosureSEC source: 0001237899-20-000008 · edgardoc.xml · nonDerivative · entry 2 STAHL NEIL · CIK 0001226689 · EVP Research and Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,658 F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c). Read SEC document |
| February 12, 2020 Filed Feb 14, 2020 21:09 UTC |
STAHL NEILEVP Research and Development
|
Exercise / conversionCommon Stock | 25,000 | $52.03 | $1,300,750.00 |
DisclosureSEC source: 0001237899-20-000008 · edgardoc.xml · nonDerivative · entry 1 STAHL NEIL · CIK 0001226689 · EVP Research and Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,380 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c). Read SEC document |
| February 07, 2020 Filed Feb 10, 2020 21:45 UTC |
GOLDSTEIN JOSEPH LDirector
|
SaleCommon Stock | 1,000 | $382.83 | $382,830.00 |
DisclosureSEC source: 0001237899-20-000007 · edgardoc.xml · nonDerivative · entry 1 GOLDSTEIN JOSEPH L · CIK 0001225474 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,643 F1 · price: Represents volume-weighted average price of sales of 1,000 shares of Company stock on February 7, 2020 at prices ranging from $382.79 to $382.83. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 7, 2020 at each separate price. Read SEC document |
| January 27, 2020 Filed Jan 28, 2020 22:06 UTC |
MURPHY ANDREW JEVP Research
|
SaleCommon Stock | 214 | $343.02 | $73,406.28 |
DisclosureSEC source: 0001237899-20-000006 · edgardoc.xml · nonDerivative · entry 8 MURPHY ANDREW J · CIK 0001796226 · EVP Research 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,951 F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c). F9 · price: Represents volume-weighted average price of sales of 214 shares of Company stock on January 27, 2020 at prices ranging from $343.00 to $343.02. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on January 27, 2020 at each separate price. Read SEC document |
| January 27, 2020 Filed Jan 28, 2020 22:06 UTC |
MURPHY ANDREW JEVP Research
|
SaleCommon Stock | 1,399 | $342.44 | $479,073.56 |
DisclosureSEC source: 0001237899-20-000006 · edgardoc.xml · nonDerivative · entry 7 MURPHY ANDREW J · CIK 0001796226 · EVP Research 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,165 F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c). F8 · price: Represents volume-weighted average price of sales of 1,399 shares of Company stock on January 27, 2020 at prices ranging from $342.00 to $342.88. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on January 27, 2020 at each separate price. Read SEC document |
| January 27, 2020 Filed Jan 28, 2020 22:06 UTC |
MURPHY ANDREW JEVP Research
|
SaleCommon Stock | 3,283 | $341.58 | $1,121,407.14 |
DisclosureSEC source: 0001237899-20-000006 · edgardoc.xml · nonDerivative · entry 6 MURPHY ANDREW J · CIK 0001796226 · EVP Research 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,564 F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c). F7 · price: Represents volume-weighted average price of sales of 3,283 shares of Company stock on January 27, 2020 at prices ranging from $341.03 to $341.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on January 27, 2020 at each separate price. Read SEC document |
| January 27, 2020 Filed Jan 28, 2020 22:06 UTC |
MURPHY ANDREW JEVP Research
|
SaleCommon Stock | 1,355 | $340.56 | $461,458.80 |
DisclosureSEC source: 0001237899-20-000006 · edgardoc.xml · nonDerivative · entry 5 MURPHY ANDREW J · CIK 0001796226 · EVP Research 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,847 F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c). F6 · price: Represents volume-weighted average price of sales of 1,355 shares of Company stock on January 27, 2020 at prices ranging from $340.05 to $340.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on January 27, 2020 at each separate price. Read SEC document |
| January 27, 2020 Filed Jan 28, 2020 22:06 UTC |
MURPHY ANDREW JEVP Research
|
SaleCommon Stock | 567 | $339.37 | $192,422.79 |
DisclosureSEC source: 0001237899-20-000006 · edgardoc.xml · nonDerivative · entry 4 MURPHY ANDREW J · CIK 0001796226 · EVP Research 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,202 F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c). F5 · price: Represents volume-weighted average price of sales of 567 shares of Company stock on January 27, 2020 at prices ranging from $339.01 to $339.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on January 27, 2020 at each separate price. Read SEC document |
| January 27, 2020 Filed Jan 28, 2020 22:06 UTC |
MURPHY ANDREW JEVP Research
|
SaleCommon Stock | 712 | $338.54 | $241,040.48 |
DisclosureSEC source: 0001237899-20-000006 · edgardoc.xml · nonDerivative · entry 3 MURPHY ANDREW J · CIK 0001796226 · EVP Research 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,769 F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c). F4 · price: Represents volume-weighted average price of sales of 712 shares of Company stock on January 27, 2020 at prices ranging from $338.07 to $338.93. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on January 27, 2020 at each separate price. Read SEC document |
| January 27, 2020 Filed Jan 28, 2020 22:06 UTC |
MURPHY ANDREW JEVP Research
|
SaleCommon Stock | 270 | $337.46 | $91,114.20 |
DisclosureSEC source: 0001237899-20-000006 · edgardoc.xml · nonDerivative · entry 2 MURPHY ANDREW J · CIK 0001796226 · EVP Research 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,481 F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c). F3 · price: Represents volume-weighted average price of sales of 270 shares of Company stock on January 27, 2020 at prices ranging from $337.01 to $337.95. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on January 27, 2020 at each separate price. Read SEC document |
| January 27, 2020 Filed Jan 28, 2020 22:06 UTC |
MURPHY ANDREW JEVP Research
|
SaleCommon Stock | 200 | $336.78 | $67,356.00 |
DisclosureSEC source: 0001237899-20-000006 · edgardoc.xml · nonDerivative · entry 1 MURPHY ANDREW J · CIK 0001796226 · EVP Research 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,751 F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c). F2 · price: Represents volume-weighted average price of sales of 200 shares of Company stock on January 27, 2020 at prices ranging from $336.55 to $336.93. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on January 27, 2020 at each separate price. Read SEC document |
| January 24, 2020 Filed Jan 27, 2020 21:04 UTC |
Fenimore Christopher R.VP Controller
|
Exercise / conversionIncentive Stock Option (right to buy) · Derivative | 500 | $0.00 Strike: $30.63 | $0.00 |
DisclosureSEC source: 0001237899-20-000005 · edgardoc.xml · derivative · entry 6 Fenimore Christopher R. · CIK 0001697422 · VP Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,380 Underlying: Common Stock · 500 shares Expires 2020-12-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The stock option award (combined incentive stock option and non-qualified stock option) vests in four equal annual installments, commencing one year after the date of grant. Read SEC document |
| January 24, 2020 Filed Jan 27, 2020 21:04 UTC |
Fenimore Christopher R.VP Controller
|
Exercise / conversionCommon Stock | 500 | $30.63 | $15,315.00 |
DisclosureSEC source: 0001237899-20-000005 · edgardoc.xml · nonDerivative · entry 1 Fenimore Christopher R. · CIK 0001697422 · VP Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,097 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 03, 2020 Filed May 22, 2020 22:21 UTC |
VAGELOS P ROYDirector · Chairman of the Board
|
GiftCommon Stock | 564 | $0.00 | $0.00 |
DisclosureSEC source: 0001708138-20-000062 · edgardoc.xml · nonDerivative · entry 3 VAGELOS P ROY · CIK 0001013064 · Director · Chairman of the Board 10b5-1 filing: Not disclosed Ownership: Indirect · by CLAT Disclosed balance after: 144,333 Read SEC document |
| January 02, 2020 Filed Jan 6, 2020 21:05 UTC |
POON CHRISTINE ADirector
|
GrantNon-Qualified Stock Option (right to buy) · Derivative | 4,361 | $0.00 Strike: $374.12 | $0.00 |
DisclosureSEC source: 0001708138-20-000008 · edgardoc.xml · derivative · entry 2 POON CHRISTINE A · CIK 0001189014 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,361 Underlying: Common Stock · 4,361 shares Expires 2030-01-02 F2 · derivative.exercise_date: On the date of the Issuer's first annual meeting of shareholders following the date of grant, a portion of these stock options equal to the portion of one year that has passed from the date of grant shall then become exercisable, and the remainder shall become exercisable on the first anniversary of the date of grant. Read SEC document |
| January 02, 2020 Filed Jan 6, 2020 21:05 UTC |
POON CHRISTINE ADirector
|
GrantCommon Stock | 320 | $0.00 | $0.00 |
DisclosureSEC source: 0001708138-20-000008 · edgardoc.xml · nonDerivative · entry 1 POON CHRISTINE A · CIK 0001189014 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,433 F1 · kind: Reflects an acquisition of time-based vesting restricted stock units each representing a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| January 02, 2020 Filed Jan 6, 2020 21:04 UTC |
Zoghbi Huda YDirector
|
GrantNon-Qualified Stock Option (right to buy) · Derivative | 4,361 | $0.00 Strike: $374.12 | $0.00 |
DisclosureSEC source: 0001708138-20-000006 · edgardoc.xml · derivative · entry 2 Zoghbi Huda Y · CIK 0001681643 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,361 Underlying: Common Stock · 4,361 shares Expires 2030-01-02 F2 · derivative.exercise_date: On the date of the Issuer's first annual meeting of shareholders following the date of grant, a portion of these stock options equal to the portion of one year that has passed from the date of grant shall then become exercisable, and the remainder shall become exercisable on the first anniversary of the date of grant. Read SEC document |
| January 02, 2020 Filed Jan 6, 2020 21:04 UTC |
Zoghbi Huda YDirector
|
GrantCommon Stock | 320 | $0.00 | $0.00 |
DisclosureSEC source: 0001708138-20-000006 · edgardoc.xml · nonDerivative · entry 1 Zoghbi Huda Y · CIK 0001681643 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 643 F1 · kind: Reflects an acquisition of time-based vesting restricted stock units each representing a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| January 02, 2020 Filed Jan 6, 2020 21:07 UTC |
Tessier-Lavigne MarcDirector
|
GrantNon-Qualified Stock Option (right to buy) · Derivative | 4,361 | $0.00 Strike: $374.12 | $0.00 |
DisclosureSEC source: 0001708138-20-000010 · edgardoc.xml · derivative · entry 2 Tessier-Lavigne Marc · CIK 0001437435 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,361 Underlying: Common Stock · 4,361 shares Expires 2030-01-02 F2 · derivative.exercise_date: On the date of the Issuer's first annual meeting of shareholders following the date of grant, a portion of these stock options equal to the portion of one year that has passed from the date of grant shall then become exercisable, and the remainder shall become exercisable on the first anniversary of the date of grant. Read SEC document |
| January 02, 2020 Filed Jan 6, 2020 21:07 UTC |
Tessier-Lavigne MarcDirector
|
GrantCommon Stock | 320 | $0.00 | $0.00 |
DisclosureSEC source: 0001708138-20-000010 · edgardoc.xml · nonDerivative · entry 1 Tessier-Lavigne Marc · CIK 0001437435 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,830 F1 · kind: Reflects an acquisition of time-based vesting restricted stock units each representing a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| January 02, 2020 Filed Jan 6, 2020 21:03 UTC |
Bassler Bonnie LDirector
|
GrantNon-Qualified Stock Option (right to buy) · Derivative | 4,361 | $0.00 Strike: $374.12 | $0.00 |
DisclosureSEC source: 0001708138-20-000004 · edgardoc.xml · derivative · entry 2 Bassler Bonnie L · CIK 0001683607 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,361 Underlying: Common Stock · 4,361 shares Expires 2030-01-02 F2 · derivative.exercise_date: On the date of the Issuer's first annual meeting of shareholders following the date of grant, a portion of these stock options equal to the portion of one year that has passed from the date of grant shall then become exercisable, and the remainder shall become exercisable on the first anniversary of the date of grant. Read SEC document |
| January 02, 2020 Filed Jan 6, 2020 21:03 UTC |
Bassler Bonnie LDirector
|
GrantCommon Stock | 320 | $0.00 | $0.00 |
DisclosureSEC source: 0001708138-20-000004 · edgardoc.xml · nonDerivative · entry 1 Bassler Bonnie L · CIK 0001683607 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 643 F1 · kind: Reflects an acquisition of time-based vesting restricted stock units each representing a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| January 02, 2020 Filed Jan 6, 2020 21:03 UTC |
BROWN MICHAEL SDirector
|
GrantNon-Qualified Stock Option (right to buy) · Derivative | 4,361 | $0.00 Strike: $374.12 | $0.00 |
DisclosureSEC source: 0001237899-20-000004 · edgardoc.xml · derivative · entry 4 BROWN MICHAEL S · CIK 0001174475 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,361 Underlying: Common Stock · 4,361 shares Expires 2030-01-02 F3 · derivative.exercise_date: On the date of the Issuer's first annual meeting of shareholders following the date of grant, a portion of these stock options equal to the portion of one year that has passed from the date of grant shall then become exercisable, and the remainder shall become exercisable on the first anniversary of the date of grant. Read SEC document |
| January 02, 2020 Filed Jan 6, 2020 21:03 UTC |
BROWN MICHAEL SDirector
|
GrantCommon Stock | 320 | $0.00 | $0.00 |
DisclosureSEC source: 0001237899-20-000004 · edgardoc.xml · nonDerivative · entry 1 BROWN MICHAEL S · CIK 0001174475 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 643 F1 · kind: Reflects an acquisition of time-based vesting restricted stock units each representing a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| January 02, 2020 Filed Jan 6, 2020 21:03 UTC |
GOLDSTEIN JOSEPH LDirector
|
GrantNon-Qualified Stock Option (right to buy) · Derivative | 4,361 | $0.00 Strike: $374.12 | $0.00 |
DisclosureSEC source: 0001237899-20-000003 · edgardoc.xml · derivative · entry 2 GOLDSTEIN JOSEPH L · CIK 0001225474 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,361 Underlying: Common Stock · 4,361 shares Expires 2030-01-02 F2 · derivative.exercise_date: On the date of the Issuer's first annual meeting of shareholders following the date of grant, a portion of these stock options equal to the portion of one year that has passed from the date of grant shall then become exercisable, and the remainder shall become exercisable on the first anniversary of the date of grant. Read SEC document |
| January 02, 2020 Filed Jan 6, 2020 21:03 UTC |
GOLDSTEIN JOSEPH LDirector
|
GrantCommon Stock | 320 | $0.00 | $0.00 |
DisclosureSEC source: 0001237899-20-000003 · edgardoc.xml · nonDerivative · entry 1 GOLDSTEIN JOSEPH L · CIK 0001225474 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,643 F1 · kind: Reflects an acquisition of time-based vesting restricted stock units each representing a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| January 02, 2020 Filed Jan 6, 2020 21:03 UTC |
RYAN ARTHUR FDirector
|
GrantNon-Qualified Stock Option (right to buy) · Derivative | 4,361 | $0.00 Strike: $374.12 | $0.00 |
DisclosureSEC source: 0001237899-20-000002 · edgardoc.xml · derivative · entry 2 RYAN ARTHUR F · CIK 0001187443 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,361 Underlying: Common Stock · 4,361 shares Expires 2030-01-02 F2 · derivative.exercise_date: On the date of the Issuer's first annual meeting of shareholders following the date of grant, a portion of these stock options equal to the portion of one year that has passed from the date of grant shall then become exercisable, and the remainder shall become exercisable on the first anniversary of the date of grant. Read SEC document |
| January 02, 2020 Filed Jan 6, 2020 21:03 UTC |
RYAN ARTHUR FDirector
|
GrantCommon Stock | 320 | $0.00 | $0.00 |
DisclosureSEC source: 0001237899-20-000002 · edgardoc.xml · nonDerivative · entry 1 RYAN ARTHUR F · CIK 0001187443 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,143 F1 · kind: Reflects an acquisition of time-based vesting restricted stock units each representing a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| January 02, 2020 Filed Jan 6, 2020 21:01 UTC |
COLES N ANTHONYDirector
|
GrantNon-Qualified Stock Option (right to buy) · Derivative | 4,361 | $0.00 Strike: $374.12 | $0.00 |
DisclosureSEC source: 0001708138-20-000002 · edgardoc.xml · derivative · entry 2 COLES N ANTHONY · CIK 0001197018 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,361 Underlying: Common Stock · 4,361 shares Expires 2030-01-02 F2 · derivative.exercise_date: On the date of the Issuer's first annual meeting of shareholders following the date of grant, a portion of these stock options equal to the portion of one year that has passed from the date of grant shall then become exercisable, and the remainder shall become exercisable on the first anniversary of the date of grant. Read SEC document |
| January 02, 2020 Filed Jan 6, 2020 21:01 UTC |
COLES N ANTHONYDirector
|
GrantCommon Stock | 320 | $0.00 | $0.00 |
DisclosureSEC source: 0001708138-20-000002 · edgardoc.xml · nonDerivative · entry 1 COLES N ANTHONY · CIK 0001197018 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 643 F1 · kind: Reflects an acquisition of time-based vesting restricted stock units each representing a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| January 02, 2020 Filed Jan 6, 2020 21:02 UTC |
SING GEORGE LDirector
|
GrantNon-Qualified Stock Option (right to buy) · Derivative | 4,361 | $0.00 Strike: $374.12 | $0.00 |
DisclosureSEC source: 0001237899-20-000001 · edgardoc.xml · derivative · entry 8 SING GEORGE L · CIK 0001225471 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,361 Underlying: Common Stock · 4,361 shares Expires 2030-01-02 F5 · derivative.exercise_date: On the date of the Issuer's first annual meeting of shareholders following the date of grant, a portion of these stock options equal to the portion of one year that has passed from the date of grant shall then become exercisable, and the remainder shall become exercisable on the first anniversary of the date of grant. Read SEC document |
| January 02, 2020 Filed Jan 6, 2020 21:02 UTC |
SING GEORGE LDirector
|
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 15,000 | $0.00 Strike: $24.41 | $0.00 |
DisclosureSEC source: 0001237899-20-000001 · edgardoc.xml · derivative · entry 7 SING GEORGE L · CIK 0001225471 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 15,000 shares Expires 2020-01-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c). F4 · derivative.exercise_date: The stock option becomes exercisable in three equal annual installments, commencing one year after the date of grant. Read SEC document |
| January 02, 2020 Filed Jan 6, 2020 21:02 UTC |
SING GEORGE LDirector
|
GrantCommon Stock | 320 | $0.00 | $0.00 |
DisclosureSEC source: 0001237899-20-000001 · edgardoc.xml · nonDerivative · entry 3 SING GEORGE L · CIK 0001225471 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 115,415 F3 · kind: Reflects an acquisition of time-based vesting restricted stock units each representing a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| January 02, 2020 Filed Jan 6, 2020 21:02 UTC |
SING GEORGE LDirector
|
SaleCommon Stock | 15,000 | $371.98 | $5,579,700.00 |
DisclosureSEC source: 0001237899-20-000001 · edgardoc.xml · nonDerivative · entry 2 SING GEORGE L · CIK 0001225471 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 115,095 F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c). F2 · price: Represents volume-weighted average price of sales of 15,000 shares of the Issuer's common stock on January 2, 2020 at prices ranging from $371.98 to $371.99. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the reporting person will provide full information regarding the number of shares sold by the reporting person on January 2, 2020. Read SEC document |
| January 02, 2020 Filed Jan 6, 2020 21:02 UTC |
SING GEORGE LDirector
|
Exercise / conversionCommon Stock | 15,000 | $24.41 | $366,150.00 |
DisclosureSEC source: 0001237899-20-000001 · edgardoc.xml · nonDerivative · entry 1 SING GEORGE L · CIK 0001225471 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 130,095 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c). Read SEC document |
| December 20, 2019 Filed Dec 23, 2019 21:02 UTC |
Fenimore Christopher R.VP Controller
|
Exercise / conversionIncentive Stock Option (right to buy) · Derivative | 400 | $0.00 Strike: $30.63 | $0.00 |
DisclosureSEC source: 0001708138-19-000014 · edgardoc.xml · derivative · entry 6 Fenimore Christopher R. · CIK 0001697422 · VP Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,880 Underlying: Common Stock · 400 shares Expires 2020-12-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The stock option award vests in four equal annual installments, commencing one year after the date of grant. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.